Sun 15 Nov 2026 23:07:11 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2026-04-29
  • RTF Template


    Hessian Office For Health And Care

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Human medicinal products


    1. Authorisation Number

    :

    DE_HE_01_WDA_2023_0059 / V5 18 L 18.01 - 1249-B

    2. Name of Authorisation Holder

    :

    HELIOS Dr. Horst Schmidt Kliniken Wiesbaden GmbH

    (ORG-100036564 / LOC-100057804)

    3. Address(es) of Site(s)

    :

    Ludwig-Erhard-Strasse 100, Dotzheim, Wiesbaden, 65199, Germany 

    Aukammallee 33, Bierstadt, Wiesbaden, Hassia, 65191, Germany 

    Robert-Koch-Strasse 2, Idstein, Hassia, 65510, Germany 




    4. Legally registered address of Authorisation Holder

    :

    Ludwig-Erhard-Strasse 100, Dotzheim, Wiesbaden, 65199

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Sect 52a para 1 German Medicinal Product Act

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2024-01-03

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: HELIOS Dr. Horst Schmidt Kliniken Wiesbaden GmbH

    (ORG-100036564 / LOC-100057804)

    , Ludwig-Erhard-Strasse 100, Dotzheim, Wiesbaden, 65199, Germany   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.2. Medicinal products derived from blood 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  Location:
    Level 01, Room 01-L-37, 01-L-38, 01-L-39
    Room HISO1060 (Ward C1) Blood storage refrigerator: Sub-depot
    OP area (transition from septic to aseptic OP)
    Blood storage refrigerator

    Ref. to 3.1.2 and 3.3: medicinal products derived from blood in accordance with Directive 2002/98 EC
    • Erythrocyte concentrate inline-filtered
    • Erythrocyte concentrate irradiated inline-filtered
    • Erythrocyte concentrate inline-filtered divided
    • Erythrocyte concentrate inline-filtered divided irradiated
    • Platelets concentrate apheresis
    • Platelets concentrate pooled
    • Platelets concentrate apheresis irradiated
    • Fresh frozen plasma
    • Lyophilized human plasma
    • Erythrocyte concentrate autologous
    • Fresh frozen plasma autologous
    • Granulocytes concentrate

    Standort:
    Ebene 01, Raum 01-L-37, 01-L-38, 01-L-39
    Raum HISO1060 (Station C1) Blutkonservenkühlschrank: Subdepot
    OP-Bereich (Übergang vom septischen zum aspetischen OP)
    Blutkonservenkühlschrank

    Zu 3.1.2 und 3.3: Arzneimittel aus Blut gemäß der Richtlinie 2002/98 EG
    •  Erythrozytenkonzentrat inline-filtriert
    • Erythrozytenkonzentrat inline-filtriert bestrahlt
    • Erythrozytenkonzentrat inline-filtriert geteilt
    • Erythrozytenkonzentrat inline-filtriert geteilt bestrahlt
    • Thrombozytenkonzentrat Apherese
    • Thrombozytenkonzentrat gepoolt
    • Thrombozytenkonzentrat Apherese bestrahlt
    • Gefrierplasma
    • Lyophilisiertes Humanplasma
    • Erythrozytenkonzentrat autolog
    • Gefrierplasma autolog
    • Granulozytenkonzentrat


    Name and address of the site: HELIOS Dr. Horst Schmidt Kliniken Wiesbaden GmbH

    (ORG-100036564 / LOC-100065251)

    , Aukammallee 33, Bierstadt, Wiesbaden, Hassia, 65191, Germany   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.2. Medicinal products derived from blood 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  Location:
    DKD Wiesbaden
    Building A, 4th floor room A.428c (POCT laboratory)

    Ref. to 3.1.2 and 3.3: medicinal products derived from blood in accordance with Directive 2002/98 EC
    • Erythrocyte concentrate inline-filtered
    • Erythrocyte concentrate irradiated inline-filtered
    • Erythrocyte concentrate inline-filtered divided
    • Erythrocyte concentrate inline-filtered divided irradiated
    • Platelets concentrate apheresis
    • Platelets concentrate pooled
    • Platelets concentrate apheresis irradiated
    • Fresh frozen plasma
    • Lyophilized human plasma
    • Erythrocyte concentrate autologous
    • Fresh frozen plasma autologous
    • Granulocytes concentrate

    Standort:
    DKD Wiesbaden
    Gebäude A, 4. OG Raum A.428c (POCT-Labor)

    Zu 3.1.2 und 3.3: Arzneimittel aus Blut gemäß der Richtlinie 2002/98 EG
    • Erythrozytenkonzentrat inline-filtriert
    • Erythrozytenkonzentrat inline-filtriert bestrahlt
    • Erythrozytenkonzentrat inline-filtriert geteilt
    • Erythrozytenkonzentrat inline-filtriert geteilt bestrahlt
    • Thrombozytenkonzentrat Apherese
    • Thrombozytenkonzentrat gepoolt
    • Thrombozytenkonzentrat Apherese bestrahlt
    • Gefrierplasma
    • Lyophilisiertes Humanplasma
    • Erythrozytenkonzentrat autolog
    • Gefrierplasma autolog
    • Granulozytenkonzentrat


    Name and address of the site: HELIOS Dr. Horst Schmidt Kliniken Wiesbaden GmbH

    (ORG-100036564 / LOC-100065250)

    , Robert-Koch-Strasse 2, Idstein, Hassia, 65510, Germany   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.2. Medicinal products derived from blood 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  Location:
    Helios Clinic Idstein
    Blood storage refrigerator ID-207/1, room E 004.2 (laboratory)

    Ref. to 3.1.2 and 3.3: medicinal products derived from blood in accordance with Directive 2002/98 EC
    • Erythrocyte concentrate inline-filtered
    • Erythrocyte concentrate irradiated inline-filtered
    • Erythrocyte concentrate inline-filtered divided
    • Erythrocyte concentrate inline-filtered divided irradiated
    • Platelets concentrate apheresis
    • Platelets concentrate pooled
    • Platelets concentrate apheresis irradiated
    • Fresh frozen plasma
    • Lyophilized human plasma
    • Erythrocyte concentrate autologous
    • Fresh frozen plasma autologous
    • Granulocytes concentrate

    Standort:
    Helios Klinik Idstein
    Blutkonservenkühlschrank ID-207/1, Raum E 004.2 (Labor)

    Zu 3.1.2 und 3.3: Arzneimittel aus Blut gemäß der Richtlinie 2002/98 EG
    • Erythrozytenkonzentrat inline-filtriert
    • Erythrozytenkonzentrat inline-filtriert bestrahlt
    • Erythrozytenkonzentrat inline-filtriert geteilt
    • Erythrozytenkonzentrat inline-filtriert geteilt bestrahlt
    • Thrombozytenkonzentrat Apherese
    • Thrombozytenkonzentrat gepoolt
    • Thrombozytenkonzentrat Apherese bestrahlt
    • Gefrierplasma
    • Lyophilisiertes Humanplasma
    • Erythrozytenkonzentrat autolog
    • Gefrierplasma autolog
    • Granulozytenkonzentrat








    Reason for Withdrawing:

    Replaced by DE_HE_01_WDA_2026_0003 / V5 18 L 18.01 - 1249-B

    Ersetzt durch DE_HE_01_WDA_2026_0003 / V5 18 L 18.01 - 1249-B








    Union Format for a Wholesale Distribution Authorisation

    DE_HE_01_WDA_2023_0059 / V5 18 L 18.01 - 1249-B


    Page 1





    Loading, please wait